Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Kangsheng Gu
A Phase II, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial of Endostar in Patients With Metastatic Melanoma
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
miR‑138‑5p Modulates the Expression of Excision Repair Cross‑complementing Proteins ERCC1 and ERCC4, and Regulates the Sensitivity of Gastric Cancer Cells to Cisplatin
Oncology Reports
Medicine
Cancer Research
Oncology
Related publications
A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Duloxetine in Japanese Fibromyalgia Patients
Arthritis Research and Therapy
Rheumatology
Allergy
Immunology
Etanercept in Alzheimer Disease: A Randomized, Placebo-Controlled, Double-Blind, Phase 2 Trial
Neurology
Neurology
Multicenter, Randomized, Double-Blinded, Placebo-Controlled Phase II Study of Serelaxin in Japanese Patients With Acute Heart Failure
Circulation Journal
Medicine
Cardiovascular Medicine
Cardiology
Therapeutic Effect of Oral CF101 in Patients With Rheumatoid Arthritis: A Randomized, Double-Blind, Placebo-Controlled Phase II Study
Immunome Research
Efficacy and Safety of Trimodulin, a Novel Polyclonal Antibody Preparation, in Patients With Severe Community-Acquired Pneumonia: A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase II Trial (CIGMA Study)
Intensive Care Medicine
Critical Care
Intensive Care Medicine
Orally Active Prostacyclin Analogue Beraprost Sodium in Patients With Chronic Kidney Disease: A Randomized, Double-Blind, Placebo-Controlled, Phase II Dose Finding Trial
BMC Nephrology
Nephrology
Adjuvant Chemotherapy With Chinese Herbal Medicine Formulas Versus Placebo in Patients With Lung Adenocarcinoma After Radical Surgery: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
Biological Procedures Online
Biochemistry
Genetics
Molecular Biology
Olaparib Combined With Abiraterone in Patients With Metastatic Castration-Resistant Prostate Cancer: A Randomised, Double-Blind, Placebo-Controlled, Phase 2 Trial
The Lancet Oncology
Oncology
Mesna for Treatment of Hyperhomocysteinemia in Hemodialysis Patients: A Placebo-Controlled, Double-Blind, Randomized Trial
Clinical Journal of the American Society of Nephrology
Epidemiology
Nephrology
Critical Care
Transplantation
Intensive Care Medicine